RiboPro raises €1.2M to become leader in (m)RNA
Summary
The current COVID-19 messenger RNA vaccines have shown the potential of the technology where mRNA has ripped up conventional timelines to start testing within weeks. We are proud to be part of this journey, and look forward to working with the team to make RiboPro a global provider of top quality mRNA. In order to keep healthcare systems effective and affordable, BOM focuses on personalized treatment methods and therapeutics, digital care and applications of key technologies such as photonics, nanotechnology and robotics. Today, Rockstart is a global accelerator-VC who empowers purpose-driven founders on their way to success across four domains: Energy, AgriFood, Health and Emerging Technologies. Rockstart also creates programs that are customized to boost collaboration between startups and corporates, driving faster access to co-creation, commercial partnerships, and investment.